Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. NIVF
stocks logo

NIVF

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Valuation Metrics

The current forward P/E ratio for NewGenIvf Group Ltd (NIVF.O) is 0.55, compared to its 5-year average forward P/E of 0.06. For a more detailed relative valuation and DCF analysis to assess NewGenIvf Group Ltd 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.06
Current PE
0.55
Overvalued PE
0.30
Undervalued PE
-0.19

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.02
Undervalued PS
-0.01
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

NIVF News & Events

Events Timeline

(ET)
2025-12-02
08:11:00
NewGen Reports $3.3M Revenue for 9M, $17.5M Net Income
select
2025-11-10 (ET)
2025-11-10
08:39:44
NewGenIvf Group Launches Share Repurchase Program Worth Up to $2 Million
select
2025-11-05 (ET)
2025-11-05
09:10:33
NewGenIvf Group Designated as SAXA Representative for Gold-Backed Asset Tokenization
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
12-02SeekingAlpha
NewGenIvf Reports GAAP EPS of $96.76 and Revenue of $3.30 Million

  • Financial Performance: NewGenIvf reported a 9-month GAAP EPS of $96.76 and revenue of $3.30 million.

  • Market Expansion: The company has entered the art tokenization market with a $2 million deal.

  • Quant Rating: Seeking Alpha has provided a Quant Rating for NewGenIvf, indicating its performance metrics.

  • Historical Data: The press release includes historical earnings data and financial information for NewGenIvf.

[object Object]
Preview
7.5
10-31Newsfilter
NewGen Signs Groundbreaking Digital Assets Purchase Agreement with White Lion to Acquire Up to 600,000 Solana Tokens Worth Over $110 Million

  • NewGen's Agreement with White Lion: NewGenIvf Group Limited has entered a binding term sheet with White Lion Capital LLC for a Digital Assets Purchase Agreement involving 600,000 Solana (SOL) tokens, allowing NewGen to sell shares in exchange for these tokens over a 24-month period.

  • Focus on Digital Assets: This innovative arrangement is part of NewGen's strategy to strengthen its digital asset treasury and reflects its commitment to the blockchain and decentralized finance sectors, particularly emphasizing the potential of Solana's ecosystem.

  • Company's Growth Strategy: NewGen has been actively developing its digital asset strategy since December 2024, with a focus on real-world asset tokenization projects and has accumulated a significant amount of Solana tokens valued at approximately $2.5 million.

  • Forward-Looking Statements: The press release includes forward-looking statements regarding the potential benefits of the agreement and the company's digital asset strategy, while also highlighting various risks and uncertainties that could affect future outcomes.

[object Object]
Preview
6.5
10-10Newsfilter
Zacks Small-Cap Research Begins Coverage of NewGen

  • Company Overview: NewGenIVF Group Limited is a diversified, tech-forward entity focused on real estate development, digital asset management, and reproductive health solutions, operating through three strategic divisions: NewGenProperty, NewGenDigital, and NewGenSup.

  • Research Coverage Initiation: Zacks Small-Cap Research has initiated equity research coverage on NewGenIVF, with the full report available on their website, highlighting the company's potential for sustainable growth and high ROI across global markets.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is NewGenIvf Group Ltd (NIVF) stock price today?

The current price of NIVF is 1.49 USD — it has increased 12.88 % in the last trading day.

arrow icon

What is NewGenIvf Group Ltd (NIVF)'s business?

NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.

arrow icon

What is the price predicton of NIVF Stock?

Wall Street analysts forecast NIVF stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NIVF is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is NewGenIvf Group Ltd (NIVF)'s revenue for the last quarter?

NewGenIvf Group Ltd revenue for the last quarter amounts to 1.27M USD, decreased -16.18 % YoY.

arrow icon

What is NewGenIvf Group Ltd (NIVF)'s earnings per share (EPS) for the last quarter?

NewGenIvf Group Ltd. EPS for the last quarter amounts to -4.75 USD, decreased -114.36 % YoY.

arrow icon

What changes have occurred in the market's expectations for NewGenIvf Group Ltd (NIVF)'s fundamentals?

The market is revising No Change the revenue expectations for NIVF for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -83.72%.
arrow icon

How many employees does NewGenIvf Group Ltd (NIVF). have?

NewGenIvf Group Ltd (NIVF) has 76 emplpoyees as of December 05 2025.

arrow icon

What is NewGenIvf Group Ltd (NIVF) market cap?

Today NIVF has the market capitalization of 1.94M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free